Drug Shortage Report for SUCCINYLCHOLINE CHLORIDE INJECTION USP

Last updated on 2024-02-01 History
Report ID 193247
Drug Identification Number 02422336
Brand name SUCCINYLCHOLINE CHLORIDE INJECTION USP
Common or Proper name SUCCINYLCHOLINE CHLORIDE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SUCCINYLCHOLINE CHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20mL
ATC code M03AB
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-05-26
Estimated end date 2024-01-31
Actual end date 2024-01-31
Shortage status Resolved
Updated date 2024-02-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2024-02-01 French Compare
v13 2024-02-01 English Compare
v12 2024-01-30 English Compare
v11 2023-12-18 French Compare
v10 2023-12-18 English Compare
v9 2023-11-17 French Compare
v8 2023-10-02 French Compare
v7 2023-10-02 English Compare
v6 2023-07-20 French Compare
v5 2023-07-20 English Compare
v4 2023-07-20 English Compare
v3 2023-05-27 English Compare
v2 2023-05-26 French Compare
v1 2023-05-26 English Compare

Showing 1 to 14 of 14